Related Experiment Video
Updated: Dec 18, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Published on: November 20, 2018
Protein Aggregation in the Pathogenesis of Ischemic Stroke
1Department of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, Jiangsu, China. wshsh088@163.com.
Abstract:
Despite the distinction between ischemic stroke and neurodegenerative disorders, they share numerous pathophysiologies particularly those mediated by inflammation and oxidative stress. Although protein aggregation is considered to be a hallmark of neurodegenerative diseases, the formation of protein aggregates can be also induced within a short time after cerebral ischemia, aggravating cerebral ischemic injury. Protein aggregation uncovers a previously unappreciated molecular overlap between neurodegenerative diseases and ischemic stroke. Unfortunately, compared with neurodegenerative disease, mechanism of protein aggregation after cerebral ischemia and how this can be averted remain unclear. This review highlights current understanding on protein aggregation and its intrinsic role in ischemic stroke.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Clot Retraction and Fibrinolysis
Peripheral Artery Disease I: Introduction

